Literature DB >> 17535593

British outpatient norms for the Brief Symptom Inventory.

Christian Ryan1.   

Abstract

BACKGROUND: The Brief Symptom Inventory (BSI) is a popular measure of psychopathology frequently used as an outcome measure, but clinicians and researchers have had to rely on normative data based on US samples which may not be appropriate for the British population.
OBJECTIVES: The aim was to develop culturally relevant outpatient norms for the BSI that would reflect hypothesized differences between US and UK population in responding to items on the BSI.
METHOD: BSI and demographic data were collected for 378 patients referred to clinical psychology services in the Midlands, England, during routine practice.
RESULTS: Significantly higher rates of psychopathology were reported by the UK sample than for the normative group reported in the US.
CONCLUSION: Outpatient normative data for British participants are presented. The study examines the impact of occupational status, age and gender differences on the level of reported distress.

Entities:  

Mesh:

Year:  2007        PMID: 17535593     DOI: 10.1348/147608306X111165

Source DB:  PubMed          Journal:  Psychol Psychother        ISSN: 1476-0835            Impact factor:   3.915


  10 in total

1.  Cortisol, oxytocin, and quality of life in major depressive disorder.

Authors:  Ai Ling Tang; Susan J Thomas; Theresa Larkin
Journal:  Qual Life Res       Date:  2019-06-21       Impact factor: 4.147

2.  UEG Week 2020 Poster Presentations.

Authors: 
Journal:  United European Gastroenterol J       Date:  2020-10       Impact factor: 4.623

3.  Generational Differences in Internalized Transnegativity and Psychological Distress Among Feminine Spectrum Transgender People.

Authors:  Kasey B Jackman; Curtis Dolezal; Walter O Bockting
Journal:  LGBT Health       Date:  2017-11-03       Impact factor: 4.151

4.  Ideal Parent Figure method in the treatment of complex posttraumatic stress disorder related to childhood trauma: a pilot study.

Authors:  Federico Parra; Carol George; Khalid Kalalou; Dominique Januel
Journal:  Eur J Psychotraumatol       Date:  2017-11-16

5.  Evaluating emotional distress and health-related quality of life in patients with heart failure and their family caregivers: Testing dyadic dynamics using the Actor-Partner Interdependence Model.

Authors:  Patricia Thomson; Kate Howie; Stephen J Leslie; Neil J Angus; Federico Andreis; Robert Thomson; Andrea R M Mohan; Catherine Mondoa; Misook L Chung
Journal:  PLoS One       Date:  2020-01-08       Impact factor: 3.240

6.  A mixed methods study of an online intervention to reduce perfectionism.

Authors:  Shanara Visvalingam; Hannah L McHardy; Susanne J Norder; Natasha R Magson; Melissa M Norberg
Journal:  Curr Psychol       Date:  2022-04-04

7.  Cognitive restructuring and graded behavioural exposure for delusional appraisals of auditory hallucinations and comorbid anxiety in paranoid schizophrenia.

Authors:  Pawel D Mankiewicz; Colin Turner
Journal:  Case Rep Psychiatry       Date:  2014-09-11

8.  Characteristics and Psychiatric Symptoms of Internet Gaming Disorder among Adults Using Self-Reported DSM-5 Criteria.

Authors:  Na Ri Kim; Samuel Suk-Hyun Hwang; Jung-Seok Choi; Dai-Jin Kim; Zsolt Demetrovics; Orsolya Király; Katalin Nagygyörgy; Mark D Griffiths; So Yeon Hyun; Hyun Chul Youn; Sam-Wook Choi
Journal:  Psychiatry Investig       Date:  2015-10-27       Impact factor: 2.505

9.  Feasibility and Accessibility of a Tailored Intervention for Informal Caregivers of People with Severe Psychiatric Disorders: a Pilot Study.

Authors:  Shyhrete Rexhaj; Claude Leclerc; Charles Bonsack; Philippe Golay; Jérôme Favrod
Journal:  Front Psychiatry       Date:  2017-09-21       Impact factor: 4.157

10.  Ensemble programme for early intervention in informal caregivers of psychiatric adult patients: a protocol for a randomised controlled trial.

Authors:  Shyhrete Rexhaj; Shadya Monteiro; Philippe Golay; Claire Coloni-Terrapon; Daniel Wenger; Jérôme Favrod
Journal:  BMJ Open       Date:  2020-07-30       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.